ArticleHormones (Athens, Greece)2026
Association between cardiometabolic index and thyroid function: insights from NHANES.
Article in Hormones (Athens, Greece), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
aimsThis study aims to explore the relationship between the cardiometabolic index (CMI) and thyroid function.
methodsUsing data from the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2012 we conducted a cross-sectional study. Thyroid-related hormones and antibodies were used as dependent variables, while CMI served as the independent variable. Multivariate regression analyses were used to evaluate the association between CMI and thyroid function, followed by subgroup analyses to test the robustness of the findings.
resultsA total of 3,963 subjects, with a mean age of 50.203 ± 17.634 years, were selected to take part in this study. The population was categorized into four CMI-based groups (Q1-Q4). Participants in Q1 tended to be of younger age and female and to have a high school education or less, a higher poverty-income ratio, lower BMI, higher vitamin D levels, and no history of smoking, hypertension, diabetes mellitus, or sleep disorders. CMI is closely related to TT3 and FT3 (TT3: β = 0.737, 95% CI: 0.393-1.080; FT3: β = 0.011, 95% CI: 0.003-0.019). When the CMI score increases by one unit, TT3 will increase by 0.737 ng/dl and FT3 will increase by 0.011 pg/ml. Subgroup analyses suggested that gender, age, hypertension, and smoking affected the relationship between CMI and TT3.
conclusionThis study identified a positive association between CMI and thyroid function, with higher CMI linked to increased TT3 and FT3 levels. These findings suggest a potential metabolic connection, but longitudinal studies are needed to determine whether thyroid function can serve as a predictive marker in cardiometabolic health assessment and intervention.
Indexed as
Identifiers
41396235What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.